IDENTIFICATION OF A NEW BREAST CANCER STEM CELL PHENOTYPE (CD44+/CD24hi/CD338hi) IN A MODEL OF BASAL-LIKE TUMOR SUBTYPE

被引：0
|
作者：
Leccia, F. [1 ,2 ]
Mariotti, E. [1 ]
Di Noto, R. [1 ,3 ]
Langellotti, S. [1 ,2 ]
Orru, S. [4 ,5 ]
Del Vecchio, L. [1 ,2 ,3 ]
Salvatore, F. [1 ,2 ,3 ]
机构：
[1] Univ Naples Federico 2, CEINGE Biotecnol Avanzate, Naples, Italy
[2] Univ Naples Federico 2, Scuola Europea Med Mol SEMM, Naples, Italy
[3] Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, Naples, Italy
[4] Univ Parthenope, Fdn SDNIRCCS, Naples, Italy
[5] Univ Parthenope, Fac Sci Motorie, Naples, Italy
来源：
CYTOMETRY PART A | 2011年 / 79A卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1073 / 1074
页数：2
相关论文
共 50 条
  • [11] Identification and characterization of CD44+/CD24-ovarian cancer stem cell properties and their correlation with survival
    Meng, E.
    Shevde, L.
    Long, B.
    Sullivan, P.
    McClellan, S.
    Finan, M.
    Reed, E.
    Rocconi, R.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S49 - S50
  • [12] Tumor endothelial interaction, CD44+/CD24-stem cell signature, and prognosis in early-stage breast cancer
    Buess, M.
    Rajski, M.
    Vogel, B.
    Herrmann, R.
    Rochlitz, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [13] Expression of Potential Cancer Stem Cell Markers CD44+/CD24-in the Molecular and Genetic Subgroups of Breast Cancer
    Bane, A. L.
    Mulligan, A. M.
    Pinnaduwage, D.
    Viloria-Petit, A.
    O'Malley, F. P.
    Andrulis, I. L.
    LABORATORY INVESTIGATION, 2009, 89 : 29A - 29A
  • [14] Expression of Potential Cancer Stem Cell Markers CD44+/CD24-in the Molecular and Genetic Subgroups of Breast Cancer
    Bane, A. L.
    Mulligan, A. M.
    Pinnaduwage, D.
    Viloria-Petit, A.
    O'Malley, F. P.
    Andrulis, I. L.
    MODERN PATHOLOGY, 2009, 22 : 29A - 29A
  • [15] CD44+/CD24- phenotype predicts a poor prognosis in triple-negative breast cancer
    Wang, Hui
    Wang, Li
    Song, Ying
    Wang, Shuhuai
    Huang, Xu
    Xuan, Qijia
    Kang, Xinmei
    Zhang, Qingyuan
    ONCOLOGY LETTERS, 2017, 14 (05) : 5890 - 5898
  • [16] Runx2 is required for activity of CD44+/CD24-/low breast cancer stem cell in breast cancer development
    Zhang, Ping
    Liu, Lei
    Zhang, Lu
    He, Xiaogan
    Xu, Xiaojun
    Lu, Yaojuan
    Li, Feifei
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (05): : 2305 - 2318
  • [17] Autophagy positively regulates the CD44+CD24-/low breast cancer stem-like phenotype
    Cufi, Silvia
    Vazquez-Martin, Alejandro
    Oliveras-Ferraros, Cristina
    Martin-Castillo, Begona
    Vellon, Luciano
    Menendez, Javier A.
    CELL CYCLE, 2011, 10 (22) : 3871 - 3885
  • [18] Effect of Cell Culture Medium on the Proliferation and Stemness of CD24-/CD44+ Human Breast Cancer Stem Cells
    Nadia, Yalista Fatia
    Syahrani, Resda Akhra
    Arumsari, Sekar
    Sadikin, Mohamad
    Wanandi, Septelia Inawati
    INDONESIAN BIOMEDICAL JOURNAL, 2021, 13 (04): : 355 - 363
  • [19] The distribution of CD44+/CD24-cancer stem cells in breast cancer and its relationship with prognostic factors
    Cabuk, Devrim
    Yetimoglu, Eylem
    Simsek, Turgay
    Gacar, Gulcin
    Subasi, Cansu
    Canturk, Zafer
    Ercin, Cengiz
    Karaoz, Erdal
    Uygun, Kazim
    JOURNAL OF BUON, 2016, 21 (05): : 1121 - 1128
  • [20] CD44+ CD24-/low phenotype and resistance to trastuzumab in HER2-positive breast cancer cell lines
    不详
    PHARMACOGENOMICS, 2011, 12 (01) : 12 - 13
12345